(NewsDirect)
McapMediaWire --Umbra Applied Technologies Group, Inc. (OTC: UATG ) (UAT Group)announced today that its subsidiary, Ossifix Orthopedics has begunexpanding beyond Texas starting with southern and north-eastern partof the United States.
Over the past several weeks, the Company has onboarded five newaccount managers across eleven cities in Texas with expansion into theNew England area currently underway. The Company has slated the secondfiscal quarter of the year for expansion across four majormetropolitan cities in Louisiana and across twenty-one majormetropolitan cities in Florida.
Ossifix CEO, Mark Estrada, stated: “We arecurrently in the process of expanding operations and onboardingdistribution channels in select target regions. Additionally, in Q2 wewill launch two unique foot and ankle product lines.”
The Company projectsmore than one-hundred surgeries to be completed in Q2 alone with a 20%increase month over in growth. Results from initial surgeries havedemonstrated early ambulation trend with many patients driving thenext day. Results of the surgeries have dramatically increasedinterest in the Javelin pin which formed the basis for the Company’sdecision to start expansion and led to the Company to begin increasingits salesforce.
Constructed of select, high-density, allograft, cortical bone,the proprietary design of the Ossifix Orthopedics Javelin pin ensuresrigid fixation without pin slip or pirouetting. Manufactured of 100%allograft bone, Ossifix implants are designed for small bone,extremities, and sports medicine markets, but have applications in thecraniofacial, spine and oral surgery procedures. Resorbable implanttechnology is readily accepted and used in today’s market, bothdomestically and globally.
Ossifixs’ unique manufacturing process anddesigns yield an engineered cortical bone implant that provides securefixation and virtually eliminates any allergic or autoimmune reactionsassociated with metal or plastic/polymer implants. All OssifixOrthopedics Pin, Screw and Plate Systems are single-use surgical kitswith all necessary instruments for implantation and are based ondecades of clinical experience and use in the operating room.
Ossifix products aredesigned to be used in hospitals, ambulatory surgical centers, andspecialty clinics. Distribution is scheduled throughout North America,and globally in Latin America, Europe, Asia Paci?c, as well as theMiddle East and Africa. This global market is currently experiencingan estimated growth of 14% per year and is expected to reach $4.696billion in sales this year.
Umbra Applied Technologies Group Chief ExecutiveOfficer, Alex Umbra, commented, "The growth and interest thatOssifix has experienced is unprecedented. With the launch of theiradditional product suites coming later this year, Ossifix will be adisrupting force within a niche but significant marketsegment”.
Ossifix Orthopedics will continue to meet with hospitalsystems, surgical centers and orthopedic surgeons across the U.S. withinternational sales slated to begin later this year.
For more informationabout Ossifix Technologies go here: https://ossifixtech.com/
About Umbra AppliedTechnologies Group, Inc.
The firm is located in Tampa Florida and focuses on advancedtechnologies across many disciplines. UAT Group is a holding companywith interests in both public and private companies during the earlystages of development as well as growth stages of companies with asynergistic business model to UAT Group subsidiaries.
For more information,visit: www.uatgroup.com
Investor and MediaContact: info@uatgroup.com
NEITHER THE SECURITIESEXCHANGE COMMISSION NOR ITS REGULATION SERVICES PROVIDER ACCEPTSRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWSRELEASE.
Forward-Looking Information
This news release may include "forward-lookingstatements" including forecasts, estimates, expectations, andobjectives for future operations including but not limited to itsability to conclude a business combination with a third party, sale ofassets, return of capital or initial public offering and a secondarylisting on the OTC as a result of aforementioned and its ability tofund the exploration of its assets through the raising of equity ordebt capital or through funding by a joint venture partner that aresubject to a number of assumptions, risks, and uncertainties, many ofwhich are beyond the control of Umbra Applied Technologies Groupincluding but not limited to capital markets and securities risks andcontinued development success on technology. There can be and are noactual or implied guarantees that any of the above activities will becompleted or completed on terms acceptable to the Company and itsshareholders or approved by any regulatory authority havingjurisdiction. Such forward-looking information representsmanagement's best judgment based on information currentlyavailable. No forward-looking statement can be guaranteed and actualfuture results may vary materially. Umbra Applied Technologies Groupdoes not assume the obligation to update any forward-lookingstatement, except as required by applicable law.
ContactDetails
Umbra Applied Technologies Group, Inc.
Copyright (c) 2023 TheNewswire - All rights reserved.